779 related articles for article (PubMed ID: 17285314)
41. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
Davis JL; Salmon JH; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
[TBL] [Abstract][Full Text] [Related]
42. Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study.
Sankalia JM; Sankalia MG; Sutariya VB; Mashru RC
J Pharm Biomed Anal; 2007 May; 44(1):196-204. PubMed ID: 17398055
[TBL] [Abstract][Full Text] [Related]
43. [Determination of octreotide in human plasma by HPLC-MS with solid-phase extraction and study on the relative bioavailability of domestic and imported octreotide injections].
Ding JS; Peng WX; Zhang ZH; Li HD; Jiang XH
Yao Xue Xue Bao; 2004 Jul; 39(7):542-5. PubMed ID: 15493847
[TBL] [Abstract][Full Text] [Related]
44. Determination of echinacoside in rat serum by reversed-phase high-performance liquid chromatography with ultraviolet detection and its application to pharmacokinetics and bioavailability.
Jia C; Shi H; Wu X; Li Y; Chen J; Tu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):308-13. PubMed ID: 16931184
[TBL] [Abstract][Full Text] [Related]
45. Determination and pharmacokinetic study of nodakenin in rat plasma by RP-HPLC method.
Zhang P; Li F; Yang XW
Biomed Chromatogr; 2008 Jul; 22(7):758-62. PubMed ID: 18318015
[TBL] [Abstract][Full Text] [Related]
46. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
47. Bioavailability and pharmacokinetics of florfenicol in healthy sheep.
Shen J; Li X; Jiang H; Hsu WH
J Vet Pharmacol Ther; 2004 Jun; 27(3):163-8. PubMed ID: 15189302
[TBL] [Abstract][Full Text] [Related]
48. Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.
Pozharitskaya ON; Karlina MV; Shikov AN; Kosman VM; Makarova MN; Makarov VG
Phytomedicine; 2009 Mar; 16(2-3):244-51. PubMed ID: 19110406
[TBL] [Abstract][Full Text] [Related]
49. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
50. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of CPU0213, a novel endothelin receptor antagonist, after intravenous administration in mice.
Guan L; Feng Y; Ji M; Dai DZ
Acta Pharmacol Sin; 2006 Mar; 27(3):367-71. PubMed ID: 16490175
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
53. A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.
Zhou ZL; Yang M; Yu XY; Peng HY; Shan ZX; Chen SZ; Lin QX; Liu XY; Chen TF; Zhou SF; Lin SG
Biomed Chromatogr; 2007 Oct; 21(10):1045-51. PubMed ID: 17549677
[TBL] [Abstract][Full Text] [Related]
54. Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration.
Mainardes RM; Palmira D Gremião M
Biol Res; 2009; 42(3):357-64. PubMed ID: 19915744
[TBL] [Abstract][Full Text] [Related]
55. [Measurement of plasma concentration and bioavailability of nolatrexed dihydrochloride in mice].
Wang GF; Zhang JY; Wu SY; Xu W; Wan SH; Shao CF; Zhang JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1993-5. PubMed ID: 19033111
[TBL] [Abstract][Full Text] [Related]
56. A HPLC method for determination of nicousamide in dog plasma and its application to pharmacokinetic studies.
Sheng L; Chen H; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):99-103. PubMed ID: 17452131
[TBL] [Abstract][Full Text] [Related]
57. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of cetirizine in healthy cats.
Papich MG; Schooley EK; Reinero CR
Am J Vet Res; 2008 May; 69(5):670-4. PubMed ID: 18447800
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous determination of a new antituberculosis agent KBF-611 and its de-acetylated metabolite in mouse and rabbit plasma by HPLC.
Shahab FM; Kobarfard F; Dadashzadeh S
Arch Pharm Res; 2009 Oct; 32(10):1453-60. PubMed ID: 19898810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
